Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up-Reference-Cited by-同舟云学术

Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up

Published:2012-02-10 Issue:5 Volume:30 Page:567-570
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Schneiders Famke L.¹,de Bruin Renée C.G.¹,van den Eertwegh Alfons J.M.¹,Scheper Rik J.¹,Leemans C. René¹,Brakenhoff Ruud H.¹,Langendijk Johannes A.²,Verheul Henk M.W.¹,de Gruijl Tanja D.¹,Molling Johan W.³,van der Vliet Hans J.¹

Affiliation:

1. VU University Medical Center, Amsterdam, the Netherlands

2. University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

3. University Medical Center Utrecht, Utrecht, the Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.38.8819

Reference5 articles.

1. Management of Cancer of the Head and Neck — A Cocktail with Your PORT?

2. Low Levels of Circulating Invariant Natural Killer T Cells Predict Poor Clinical Outcome in Patients With Head and Neck Squamous Cell Carcinoma

3. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

4. Natural Killer T Cell–Based Cancer Immunotherapy: Fig. 1.

5. Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR Cells beyond Classical CAR T Cells: Functional Properties and Prospects of Application;Biochemistry (Moscow);2024-05

2. IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity;Nature Communications;2024-01-02

3. Efficacy of Invariant Natural Killer T Cell Infusion Plus Transarterial Embolization vs Transarterial Embolization Alone for Hepatocellular Carcinoma Patients: A Phase 2 Randomized Clinical Trial;Journal of Hepatocellular Carcinoma;2023-08

4. The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy;Cancers;2023-03-07

5. SOX chemotherapy with anti-PD-1 and iNKT cell immunotherapies for stage IV gastric adenocarcinoma with liver metastases: A case report;Frontiers in Immunology;2022-12-12